BRC Group Holdings RILYN Q1 2024 Earnings Net Loss of 171 per Share Reflects Ongoing Pressures Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech HOVNP Q1 2026 Earnings Preferred Shares Report NarrowerThanExpected Loss Chevron Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiencies Reviva Pharmaceuticals RVPH Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Drives SmallerThanExpected Loss EH Q4 2025 Earnings Massive EPS Beat Drives Positive Surprise Despite Revenue Absence